Sodium and proton coupling in the conformational cycle of a MATE antiporter from Vibrio cholerae
Sodium and proton coupling in the conformational cycle of a MATE antiporter from Vibrio cholerae
复制标题
DOI:
10.1073/pnas.1802417115
复制
发表时间:
2018-07-03
影响因子:
11.1
通讯作者:
Mchaourab, Hassane S.
中科院分区:
文献类型:
--
作者:
Claxton, Derek P.;Jagessar, Kevin L.;Mchaourab, Hassane S.
Secondary active transporters belonging to the multidrug and toxic compound extrusion (MATE) family harness the potential energy of electrochemical ion gradients to export a broad spectrum of cytotoxic compounds, thus contributing to multidrug resistance. The current mechanistic understanding of ion-coupled substrate transport has been informed by a limited set of MATE transporter crystal structures from multiple organisms that capture a 12-transmembrane helix topology adopting similar outward-facing conformations. Although these structures mapped conserved residues important for function, the mechanistic role of these residues in shaping the conformational cycle has not been investigated. Here, we use double-electron electron resonance (DEER) spectroscopy to explore ligand-dependent conformational changes of NorM from Vibrio cholerae (NorM-Vc), a MATE transporter proposed to be coupled to both Na+ and H+ gradients. Distance measurements between spin labels on the periplasmic side of NorM-Vc identified unique structural intermediates induced by binding of Na+, H+, or the substrate doxorubicin. The Na+-and H+-dependent intermediates were associated with distinct conformations of TM1. Sitedirected mutagenesis of conserved residues revealed that Na+-and H+-driven conformational changes are facilitated by a network of polar residues in the N-terminal domain cavity, whereas conserved carboxylates buried in the C-terminal domain are critical for stabilizing the drug-bound state. Interpreted in conjunction with doxorubicin binding of mutant NorM-Vc and cell toxicity assays, these results establish the role of ion-coupled conformational dynamics in the functional cycle and implicate H+ in the doxorubicin release mechanism.